New 52 Week Low Today

Decibel Therapeutics Inc DBTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/16/21 EDT
9.89UNCH (UNCH)
Volume
446
Close
9.89quote price arrow down-0.86 (-8.00%)
Volume
68,124
52 week range
9.83 - 24.39

...

Loading . . .
  • Open10.83
  • Day High10.86
  • Day Low9.83
  • Prev Close10.75
  • 52 Week High24.39
  • 52 Week High Date02/12/21
  • 52 Week Low9.83
  • 52 Week Low Date04/16/21

Key Stats

  • Market Cap246.26M
  • Shares Out24.90M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open10.83
  • Day High10.86
  • Day Low9.83
  • Prev Close10.75
  • 52 Week High24.39
  • 52 Week High Date02/12/21
  • 52 Week Low9.83
  • 52 Week Low Date04/16/21
  • Market Cap246.26M
  • Shares Out24.90M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-2.22
  • P/E (TTM)-4.46
  • Fwd P/E (NTM)-5.36
  • EBITDA (MRQ)-27.668M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Decibel Therapeutics Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Decibel Therapeutics Inc is a clinical-stage biotechnology company. The Company is focused on discovering and developing transformative treatments for hearing and balance disorders. The Company is focused on restoring and improving hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear. The Company has built a platform that integrates single-cell genomics and bioinformatics analyses, precision...
Laurence Reid Ph.D.
Chief Executive Officer
Elisabeth Leiderman M.D.
Chief Financial Officer
Address
1325 Boylston Street, Suite 500
Boston, MA
02215
United States